Skip to Content

Join the 'Myobloc' group to help and get support from people like you.

Myobloc News

Botox Can Be Used for Chronic Migraine, Experts Say

Posted 18 Apr 2016 by Drugs.com

MONDAY, April 18, 2016 – Botox is a safe and effective treatment for chronic migraine and three other neurological disorders, an updated guideline from the American Academy of Neurology says. Long used to smooth wrinkles, botulinum toxin is made by a type of bacteria. The toxin blocks the release of substances at nerve endings, reducing muscle contraction and the transmission of pain signals, the researchers explained. The authors of the updated guideline reviewed scientific studies on the four preparations of botulinum toxin available in the United States. They concluded that the treatment is generally safe and effective for four neurological conditions: chronic migraine, spasticity in adults, cervical dystonia and blepharospasm. Chronic migraine is defined as having migraines 15 or more days a month, the study authors explained. Spasticity in adults is muscle tightness that ... Read more

Related support groups: Migraine, Migraine Prevention, Migraine Prophylaxis, Facial Wrinkles, Cervical Dystonia, Chronic Spasticity, Blepharospasm, Spasticity, Upper Limb Spasticity, Lower Limb Spasticity, Myobloc, Spinal Spasticity, Botulinum Toxin Type B

Americans Embraced Record Number of Lip Procedures in 2015

Posted 18 Apr 2016 by Drugs.com

MONDAY, April 18, 2016 – Hoping to look more kissable perhaps, Americans underwent a record number of lip procedures last year. "We live in the age of the selfie, and because we see images of ourselves almost constantly on social media, we're much more aware of how our lips look," Dr. David Song, president of the American Society of Plastic Surgeons, said in a society news release. There were more than 27,400 lip implants performed in 2015 – a 48 percent increase since 2000. That averages out to one lip implant every 19 minutes, the society said, noting the procedure became more popular among both men and women. Lip injections, which include Botox and various soft-tissue fillers, also rose steeply last year, reaching nearly 9.2 million. That's an increase of more than 1,000 percent since the year 2000, the plastic surgeons said. Lip procedures have been the second-fastest-growing ... Read more

Related support groups: Botox, Facial Wrinkles, Myobloc, Facial Lipoatrophy, Botulinum Toxin Type B, Orbicularis Oculi, Lip Augmentation

Why Skin Wrinkles More Around the Eyes

Posted 17 Jul 2015 by Drugs.com

FRIDAY, July 17, 2015 – Facial wrinkles – such as so-called "laugh lines" or "crow's feet" – are the bane of many aging adults. Now, new research on cadavers may offer some insight into why some skin creases are more pronounced than others. Differences in oil-secreting glands just below the skin may help explain why forehead wrinkles are shallower than wrinkles around the outer eye, according to a research team led by Yuichi Tamatsu, of Kagoshima University Graduate School of Medical and Dental Sciences in Japan. Sebaceous glands are "microscopic glands that secrete sebum, an oily or waxy material, which lubricates the skin and protects it from water damage," said Dr. Nitin Chauhan, a facial plastic and reconstructive surgeon and otolaryngologist at the University of Toronto. Chauhan, who was not part of the new research, said that based on the study findings, it appears that ... Read more

Related support groups: Facial Wrinkles, Photoaging of the Skin, Myobloc, Facial Lipoatrophy, Dermatoheliosis, Botulinum Toxin Type B, Orbicularis Oculi

Medication Errors Occur Every 8 Minutes in U.S. Children

Posted 20 Oct 2014 by Drugs.com

MONDAY, Oct. 20, 2014 – A child receives the wrong medication or the wrong dosage every eight minutes in the United States, according to a recent study. Nearly 700,000 children under 6 years old experienced an out-of-hospital medication error between 2002 and 2012. Out of those episodes, one out of four children was under a year old. As the age of children decreased, the likelihood of an error increased, the study found. Though 94 percent of the mistakes didn't require medical treatment, the errors led to 25 deaths and about 1,900 critical care admissions, according to the study. "Even the most conscientious parents make errors," said lead author Dr. Huiyun Xiang, director of the Center for Pediatric Trauma Research at Nationwide Children's Hospital in Columbus, Ohio. That conscientiousness may even lead to one of the most common errors: Just over a quarter of these mistakes involved a ... Read more

Related support groups: Xanax, Klonopin, Clonazepam, Seroquel, Ativan, Valium, Abilify, Lorazepam, Alprazolam, Azithromycin, Diazepam, Soma, Benadryl, Flexeril, Latuda, Risperidone, Cyclobenzaprine, Geodon, Baclofen, Zyprexa

Accidental Medication Poisonings in Kids on the Rise

Posted 16 Sep 2011 by Drugs.com

FRIDAY, Sept. 16 – Despite ongoing prevention efforts, a growing number of young children are being accidentally poisoned with medications, according to new research. The study, which was based on data reported to the American Association of Poison Control Centers between 2001 and 2008, found that medication poisoning among children aged 5 and under increased by 22 percent, although the number of children in the United States in this age group rose by only 8 percent during the study period. "The problem of pediatric poisoning in the U.S. is getting worse, not better," Dr. Randall Bond, of Cincinnati Children's Hospital Medical Center, said in a hospital news release. In conducting the study, which is scheduled for publication in the Journal of Pediatrics, the researchers reviewed information on over 544,000 children who landed in the emergency department due to medication poisoning ... Read more

Related support groups: Xanax, Suboxone, Oxycodone, Hydrocodone, Methadone, Percocet, OxyContin, Klonopin, Vicodin, Lisinopril, Norco, Fentanyl, Clonazepam, Morphine, Ativan, Ambien, Valium, Codeine, Metoprolol, Lortab

FDA Medwatch Alert: Botox and Botox Cosmetic (Botulinum toxin Type A) and Myobloc (Botulinum toxin Type B)

Posted 30 Apr 2009 by Drugs.com

FDA notified healthcare professionals that after an ongoing safety review initiated in February 2008, the manufacturers of licensed botulinum toxin products will be required by FDA to strengthen warnings in product labeling and add a boxed warning regarding the risk of adverse events when the effects of the toxin spread beyond the site where it was injected. FDA will also require that manufacturers develop and implement a Risk Evaluation and Mitigation Strategy [REMS], including a communication plan to provide more information regarding the risk for distant spread of botulinum toxin effects after local injection, as well as information to explain that botulinum toxin products cannot be interchanged. The REMS would also include a Medication Guide that explains the risks to patients, their families, and caregivers. FDA is requiring the manufacturers to submit safety data after multiple ... Read more

Related support groups: Botox, Botox Cosmetic, Myobloc

FDA Medwatch Alert: Botox, Botox Cosmetic (Botulinum toxin Type A), Myobloc (Botulinum toxin Type B)

Posted 8 Feb 2008 by Drugs.com

[Posted 02/07/2008] FDA issued an early communication about an ongoing safety review regarding Botox and Botox Cosmetic. FDA has received reports of systemic adverse reactions including respiratory compromise and death following the use of botulinum toxins types A and B for both FDA-approved and unapproved uses. The reactions reported are suggestive of botulism, which occurs when botulinum toxin spreads in the body beyond the site where it was injected. The most serious cases had outcomes that included hospitalization and death, and occurred mostly in children treated for cerebral palsy-associated limb spasticity. Use of botulinum toxins for treatment of limb spasticity (severe arm and leg muscle spasms) in children or adults is not an approved use in the U.S. See the FDA's "Early Communication about an Ongoing Safety Review" for Agency recommendations and additional information for ... Read more

Related support groups: Botox, Botox Cosmetic, Myobloc

FDA Mandates New Warnings for Botox

Posted 30 Apr 2009 by Drugs.com

THURSDAY, April 30 – Reports of deaths among people using popular anti-wrinkle injections such as Botox to treat muscle spasms have prompted a change in labeling. Botox and similar products will now be required to carry boxed warnings, the most serious type of label warning, the U.S. Food and Drug Administration announced Thursday. Most cases involved children given the drug to control muscle spasticity associated with cerebral palsy and adults using it to treat muscle spasticity, migraines and cervical dystonia. "The hospitalizations are very few, deaths are very rare, but they have been reported," said Dr. Ellis F. Unger, acting deputy director of the FDA's Office of Drug Evaluation, said during a teleconference. "We don't want to discourage use of these drugs as patients taking them have significant disability and the drugs are effective to relieve important problems," he said. "But ... Read more

Related support groups: Botox, Myobloc

Ask a Question

Further Information

Related Condition Support Groups

Cervical Dystonia, Facial Wrinkles, Dystonia, Hyperhidrosis

Myobloc Patient Information at Drugs.com